Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Cryoport announced it will assist Sanaria in the design and implementation of the cryogenic cold chain for Sanaria’s investigational malaria vaccines.
read more
Monday, September 12, 2022
Cryoport has entered into a strategic relationship with BioLife Plasma Services, part of the global biopharmaceutical company Takeda, intended to provide consistent, high-quality cellular starting material for use in the manufacture of life-saving ...
read more
Cryoport has announced the launch of its bio-storage offering. The new offering is the result of a clear demand from Cryoport customers to complement its cryogenic logistics solutions with advanced storage and fulfillment capabilities.
read more
Cryoport, a leading global provider of innovative temperature-controlled supply chain solutions for the life sciences industry, with focus on the bio-pharmaceutical and cell and gene therapy markets, confirms that the Company does not have any ...
read more
Cryoport, a cryogenic logistics company, has announced that it will be supporting the cryogenic logistics requirements of ImmunoCellular Therapeutics' registrational Phase III glioblastoma clinical trial across 120 sites in North America and Europe.
read more
Dr. Hariri is the Chairman, Founder and Chief Scientific Officer of Celgene Cellular Therapeutics, one of the world's largest human cellular therapeutics companies and wholly owned subsidiary of Celgene Corporation.
read more
Thursday, January 19, 2023
Cryoport, Inc. announced a new strategic partnership with Syneos Health® that will support the global advancement of cell and gene therapies, providing a fully integrated biopharmaceutical and supply chain solution.
read more
Cryoport, Inc. announced a multi-year agreement with Inception Fertility™. Inception Fertility operates The Prelude Network® (Prelude), a network of fertility centers in North America, and MyEggBank®, a network of donor egg banks and practices in ...
read more
Cryoport, Inc. has announced the launch of a new Temperature Controlled Logistics Consulting Division to assist life sciences companies in developing strategies for global cold chain logistics management and contingency options to protect their ...
read more
Cryoport, Inc., a leading global provider of innovative temperature-controlled supply chain solutions to the life sciences including clinical research, pharmaceutical and cell and gene therapy markets, and Mitsubishi Logistics Corporation ("MLC"), ...
read more
Thursday, October 24, 2024
Cryoport, Inc. and Gulf Coast Regional Blood Center, a non-profit community blood center serving more than 26 counties throughout the state of Texas, announced a strategic alliance to enhance the availability of high-quality, manufacture-ready ...
read more
Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions, partners with LifeConEx, a part of DHL Global Forwarding, to enhance and supplement DHL’s cold chain logistics offerings including DHL ...
read more
Friday, September 23, 2016
Cryoport has announced the integration of its proprietary logistics technology, the Cryoportal™, with Database Integrations, Inc.'s Integrated Cell Therapy Automated Network (iCAN) scheduling platform.
read more
Thursday, January 27, 2022
Cryoport, Inc. has entered into a strategic partnership with Cell Matters, S.A. to deliver to the life sciences industry end-to-end cryopreservation services for leukapheresis derived therapies supporting both autologous and allogeneic cell therapies...
read more
Acquisition Further Expands Cryoport's Presence in Asia-Pacific Region to Address Increased Clinical Trial Activity Worldwide.
read more